Ryan Walter Hick, MD, FAAD
SESSIONS
F124 Practice Management: Vision, Execution, and Optimization
Mar 11, 2024
•
3:30 PM - 5:30 PM
•
Room 32B
DISCLOSURES
AbbVie – Stockholder(No Compensation Received); Gilead Sciences – Stockholder(No Compensation Received); Merck & Co., Inc – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received); PP Capital – Stockholder(No Compensation Received); Sonic Healthcare – Stockholder(No Compensation Received); Stingray Therapeutics – Stockholder(No Compensation Received); Walgreens Boots Alliance, Inc. – Stockholder(No Compensation Received);